• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$21.93 $0.48 (2.24%)

REAL-TIME: Last trade at

ICON plc (ADR)

NASDAQ:ICLR

ICON plc upgraded to Buy from Neutral at Lazard Capital

Wells Fargo Upgrades ICON plc (ICLR) to Outperform; Revenue Ramping

ICON plc upgraded to Outperform from Market Perform at Wells Fargo

ICON plc upgraded to Buy from Neutral at Sterne Agee

Icon Plc (ICLR) Reports In-Line Q1 EPS of 15c

ICON reports Q1 EPS 15c, consensus 15c

ICON reports a 10% increase in first quarter 2012 revenue to $252m, up 10% year on year, EPS of 15 cents, net new business awards of $385 million and a B:B of 1.5. (NASDAQ:ICLR) (ISIN:IE0005711209)

Nimble Approach to Partnerships Will Generate Value for Both CROs and the Pharmaceutical Industry, According to New Study

Our Outlook for Health-Care Stocks

ICON plc (ICLR) Becomes Roche (RHHBY) Tech Partner for Clinical Research Programs

ICON plc selected by Roche for technology partnership

ICON Selected by Roche for Technology Partnership

ICON plc acquires PriceSpective; terms were not disclosed

ICON Acquires PriceSpective

Jefferies Boosts Price Target ICON plc (ICLR) After Q4 Results, Maintains Hold

ICON Falls Shy of Our EPS Estimate in 4Q, But Earnings Set to Double in 2012

Icon Plc (ICLR) Tops Q4 EPS Views; Guides FY12 EPS, Revs

ICON plc sees FY12 EPS 90c-$1.10 vs. consensus 99c

ICON plc appoints Brendan Brennan as CFO

ICON plc reports Q4 EPS 7c vs. consensus 9c

ICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (ISIN:IE0005711209)

ICON plc upgraded to Neutral from Underperform at Sterne Agee

10 Top Morningstar M&A Stock Picks

The Long-Term Play In Lab Work (BBH, CRL, ICLR, PRXL, WX)

CROs Will Return to Relevance in 2012

ICON chosen by Shire plcs Specialty Pharma's unit as global strategic partner

ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services

Davy Securities to host a conference

Deutsche Bank hosts a Life Science Tools & Diagnostics/Industry conference call

Deutsche Bank Downgrades ICON plc (ICLR) to Hold; Limited Near-Term EPS Visibility

Follow-up: ICON plc downgraded to Hold from Buy at Deutsche Bank

ICON Announces Dr. Anthony Murphy To Retire From Board of Directors

ICON Announces Dr. Anthony Murphy To Retire From Board of Directors

EU Treaty Fallout: 9 Stocks That May Buck the Trend

Don't Get Too Worked Up Over ICON's Earnings

ICON plc acquires BeijingWits Medical Consulting Ltd

ICON Acquires BeijingWits Medical Consulting Ltd

7 Life Science Stocks to Sell

ICON plc: Commencement of Share Repurchase Programme

ICON to begin announced $50M repurchase program

See More Articles...